S. Molica
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 13
- Chronic Lymphocytic Leukemia Research 10
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Hematology 11
- Multiple Myeloma Research and Treatments 4
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Domenico Levato (3 shared papers)Piero Galieni (2 shared papers)Venerino Poletti (1 shared paper)Alfonso Zaccaria (1 shared paper)Michela Ribersani (1 shared paper)Maurizio Martelli (1 shared paper)Rosario Giustolisi (1 shared paper)Francesco Zaja (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)American Journal of Hematology (2 papers)Blood (2 papers)Acta Haematologica (2 papers)Chemotherapy (1 paper)
- Partner nations
- ItalyUnited Kingdom
In The Last Decade
S. Molica
25 papers receiving 532 citations
Peers
Comparison fields: 5 of 41
- Genetics 165
- Pathology and Forensic Medicine 250
- Hematology 124
- Oncology 145
- Neurology 60
Countries citing papers authored by S. Molica
This map shows the geographic impact of S. Molica's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Molica with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Molica more than expected).
Fields of papers citing papers by S. Molica
This network shows the impact of papers produced by S. Molica. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Molica. The network helps show where S. Molica may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Molica, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 223 | |
| 2 | 2001 | 54 | |
| 3 | 1997 | 44 | |
| 4 | Infections in chronic lymphocytic leukemia. Analysis of incidence as a function of length of follow-up. | 1994 | 37 |
| 5 | Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myeloma. | 2002 | 33 |
| 6 | 2001 | 31 | |
| 7 | Recombinant alpha-2a interferon in treatment of B-chronic lymphocytic leukemia. A preliminary report with emphasis on previously untreated patients in early stage of disease. | 1990 | 20 |
| 8 | Intercellular adhesion molecules (ICAMs) 2 and 3 are frequently expressed in B cell chronic lymphocytic leukemia. | 1996 | 20 |
| 9 | 2011 | 13 | |
| 10 | Prognosis of chronic myelomonocytic leukemia. | 1996 | 13 |
| 11 | 2020 | 12 | |
| 12 | Alpha 2-interferon in B-cell chronic lymphocytic leukemia: clinical response, serum cytokine levels, and immunophenotype modulation. | 1993 | 8 |
| 13 | An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy. | 1999 | 6 |
| 14 | 2004 | 6 | |
| 15 | 1990 | 5 | |
| 16 | Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy. | 2001 | 4 |
| 17 | 2018 | 3 | |
| 18 | 1995 | 3 | |
| 19 | Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease. | 2000 | 3 |
| 20 | Alpha interferon in the treatment of chronic myelomonocytic leukemia. | 1990 | 3 |
About S. Molica
S. Molica is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Molecular Biology and Oncology, having authored 26 papers that have together received 546 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (6 papers), Multiple Myeloma Research and Treatments (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Cancer Treatment and Pharmacology (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Genetics (165 citations), Pathology and Forensic Medicine (250 citations), Hematology (124 citations), Oncology (145 citations) and Neurology (60 citations). S. Molica has collaborated with scholars based in Italy and United Kingdom. Frequent co-authors include Domenico Levato, Piero Galieni, Venerino Poletti, Alfonso Zaccaria, Michela Ribersani, Maurizio Martelli, Rosario Giustolisi, Francesco Zaja, Luciano Guardigni and Filíppo Gherlinzoni. Their work appears in journals such as Journal of Clinical Oncology, American Journal of Hematology, Blood, Acta Haematologica and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.